CVS reported first quarter earnings Thursday, blowing past Wall Street's expectations and ending anxiety over Medicare ...

Humana reported first quarter earnings that topped Wall Street expectations Wednesday, helping drive shares 5% higher in ...

Eli Lilly (LLY) reported first quarter earnings on Thursday, beating Wall Street's expectations on the top and bottom lines, ...

Humana contributed its results to staying in line with its own expectations, and has reaffirmed its full year guidance. The ...

The company now expects full-year adjusted earnings of $6 to $6.20 per share, up from a previous guidance of $5.75 to $6 per ...

CVS Health hiked its 2025 forecast above Wall Street's expectations after improving Medicare benefits contributed to a better ...

Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

CVS Health topped Q1 estimates with $94.59 billion in revenue and raised 2025 EPS outlook to $6.00–$6.20 amid strong Medicare ...

CVS Health raised its full-year profit forecast on Thursday and said it plans to exit the market for Obamacare health ...

CVS Health shares powered 9% higher before the bell Thursday after the pharmacy and healthcare giant's first-quarter results ...

That means patients will be steered to Wegovy if they are prescribed a weight-loss drug and have CVS Caremark as their pharmacy benefit manager (PBM). CVS "is taking a formulary action on July 1 ...